XML 29 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Common stock, beginning balance (in shares) at Jul. 31, 2018   38,860,571      
Beginning balance at Jul. 31, 2018 $ 505,684,000 $ 3,886,000 $ 538,453,000 $ 405,194,000 $ (441,849,000)
Treasury stock, beginning balance (in shares) at Jul. 31, 2018         15,033,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-classified stock award compensation 3,356,000   3,356,000    
Proceeds from exercises of stock options (in shares)   6,100      
Proceeds from exercises of stock options 174,000 $ 1,000 173,000    
Proceeds from issuance of employee stock purchase plan shares (in shares)   32,035      
Proceeds from issuance of employee stock purchase plan shares 709,000 $ 3,000 706,000    
Issuance of restricted stock (in shares)   10,386      
Issuance of restricted stock, net $ 0 $ 1,000 (1,000)    
Net settlement of stock-based awards (in shares) 9,345 53,438      
Net settlement of stock-based awards $ (2,069,000) $ 5,000 (2,074,000)    
Common stock issued for acquisitions (in shares)   208,669      
Common stock issued for acquisitions 5,606,000 $ 21,000 5,585,000    
Cash dividends declared (7,169,000)     (7,169,000)  
Accrual of dividend equivalents, net of reversal (248,000)     (248,000)  
Net income 18,906,000     18,906,000  
Common stock, ending balance (in shares) at Apr. 30, 2019   39,171,199      
Ending balance at Apr. 30, 2019 524,949,000 $ 3,917,000 546,198,000 416,683,000 $ (441,849,000)
Treasury stock, ending balance (in shares) at Apr. 30, 2019         15,033,317
Common stock, beginning balance (in shares) at Jan. 31, 2019   38,950,547      
Beginning balance at Jan. 31, 2019 512,877,000 $ 3,895,000 539,273,000 411,558,000 $ (441,849,000)
Treasury stock, beginning balance (in shares) at Jan. 31, 2019         15,033,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-classified stock award compensation 1,119,000   1,119,000    
Proceeds from issuance of employee stock purchase plan shares (in shares)   11,837      
Proceeds from issuance of employee stock purchase plan shares 233,000 $ 1,000 232,000    
Net settlement of stock-based awards (in shares)   146      
Net settlement of stock-based awards (11,000)   (11,000)    
Common stock issued for acquisitions (in shares)   208,669      
Common stock issued for acquisitions 5,606,000 $ 21,000 5,585,000    
Cash dividends declared (2,405,000)     (2,405,000)  
Accrual of dividend equivalents, net of reversal (82,000)     (82,000)  
Net income 7,612,000     7,612,000  
Common stock, ending balance (in shares) at Apr. 30, 2019   39,171,199      
Ending balance at Apr. 30, 2019 $ 524,949,000 $ 3,917,000 546,198,000 416,683,000 $ (441,849,000)
Treasury stock, ending balance (in shares) at Apr. 30, 2019         15,033,317
Common stock, beginning balance (in shares) at Jul. 31, 2019 39,276,161 39,276,161      
Beginning balance at Jul. 31, 2019 $ 535,082,000 $ 3,928,000 552,670,000 420,333,000 $ (441,849,000)
Treasury stock, beginning balance (in shares) at Jul. 31, 2019 15,033,317       15,033,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-classified stock award compensation $ 3,098,000   3,098,000    
Proceeds from exercises of stock options (in shares)   16,700      
Proceeds from exercises of stock options 468,000 $ 2,000 466,000    
Proceeds from issuance of employee stock purchase plan shares (in shares)   36,168      
Proceeds from issuance of employee stock purchase plan shares 690,000 $ 4,000 686,000    
Issuance of restricted stock (in shares)   3,319      
Issuance of restricted stock, net $ 0 $ 0 0    
Net settlement of stock-based awards (in shares) 27,992 109,405      
Net settlement of stock-based awards $ (3,487,000) $ 11,000 (3,498,000)    
Common stock issued for acquisitions (in shares)   323,504      
Common stock issued for acquisitions 11,575,000 $ 32,000 11,543,000    
Cash dividends declared (7,326,000)     (7,326,000)  
Accrual of dividend equivalents, net of reversal (169,000)     (169,000)  
Net income $ 5,894,000     5,894,000  
Common stock, ending balance (in shares) at Apr. 30, 2020 39,765,257 39,765,257      
Ending balance at Apr. 30, 2020 $ 545,825,000 $ 3,977,000 564,965,000 418,732,000 $ (441,849,000)
Treasury stock, ending balance (in shares) at Apr. 30, 2020 15,033,317       15,033,317
Common stock, beginning balance (in shares) at Jan. 31, 2020   39,752,559      
Beginning balance at Jan. 31, 2020 $ 551,203,000 $ 3,975,000 563,834,000 425,243,000 $ (441,849,000)
Treasury stock, beginning balance (in shares) at Jan. 31, 2020         15,033,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-classified stock award compensation 981,000   981,000    
Proceeds from issuance of employee stock purchase plan shares (in shares)   16,158      
Proceeds from issuance of employee stock purchase plan shares 180,000 $ 2,000 178,000    
Forfeiture of restricted stock (in shares)   (5,539)      
Forfeiture of restricted stock 0 $ (1,000) 1,000    
Net settlement of stock-based awards (in shares)   2,079      
Net settlement of stock-based awards (28,000) $ 1,000 (29,000)    
Cash dividends declared (2,466,000)     (2,466,000)  
Accrual of dividend equivalents, net of reversal (56,000)     (56,000)  
Net income $ (3,989,000)     (3,989,000)  
Common stock, ending balance (in shares) at Apr. 30, 2020 39,765,257 39,765,257      
Ending balance at Apr. 30, 2020 $ 545,825,000 $ 3,977,000 $ 564,965,000 $ 418,732,000 $ (441,849,000)
Treasury stock, ending balance (in shares) at Apr. 30, 2020 15,033,317       15,033,317